ReviewTuberculosis and respiratory diseases2016
The Korean Cough Guideline: Recommendation and Summary Statement.
Review in Tuberculosis and respiratory diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 43 citations in OpenAlex.
- HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.The Korean journal of internal medicine · 2020Trial
- Unbalanced Associations between Physical, Psychological, and Social Domains of the Leicester Cough Questionnaire: Network and Mediation Analyses.Tuberculosis and respiratory diseases · 2025Article
- Clinical characteristics of the early responders in the treatment of chronic cough.Journal of thoracic disease · 2025Article
- Sex Differences in Chronic Cough Epidemiology: The Korean Cough Study Group.Journal of Korean medical science · 2024Article
- Cough Characteristics and Their Association Patterns According to Cough Etiology: A Network Analysis.Journal of clinical medicine · 2023Article
- Herbal MedicineInternational journal of environmental research and public health · 2023Article
- Article
- Efficacy of non-sedating H1-receptor antihistamines in adults and adolescents with chronic cough: A systematic review.The World Allergy Organization journal · 2021Article
- Differential features of chronic cough according to etiology and the simple decision tree for predicting causes.Scientific reports · 2021Observational
- Perspectives on chronic cough in Korea.Journal of thoracic disease · 2020Review
- Cluster analysis in 975 patients with current cough identifies a phenotype with several cough triggers, many background disorders, and low quality of life.Respiratory research · 2020Observational
- Dispensing Antibiotics without a Prescription for Acute Cough Associated with Common Cold at Community Pharmacies in Shenyang, Northeastern China: A Cross-Sectional Study.Antibiotics (Basel, Switzerland) · 2020Article
- Clinical Characteristics of Chronic Cough in Korea.Tuberculosis and respiratory diseases · 2020Article
- Somatic cough syndrome or psychogenic cough-what is the difference?Journal of thoracic disease · 2017Article
- Observational
- Sex-related disparities in cough-associated symptoms across different age groups.Therapeutic advances in respiratory diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 10 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cough is one of the most common symptom of many respiratory diseases. The Korean Academy of Tuberculosis and Respiratory Diseases organized cough guideline committee and cough guideline was developed by this committee. The purpose of this guideline is to help clinicians to diagnose correctly and treat efficiently patients with cough. In this article, we have stated recommendation and summary of Korean cough guideline. We also provided algorithm for acute, subacute, and chronic cough. For chronic cough, upper airway cough syndrome (UACS), cough variant asthma (CVA), and gastroesophageal reflux disease (GERD) should be considered. If UACS is suspicious, first generation anti-histamine and nasal decongestant can be used empirically. In CVA, inhaled corticosteroid is recommended in order to improve cough. In GERD, proton pump inhibitor is recommended in order to improve cough. Chronic bronchitis, bronchiectasis, bronchiolitis, lung cancer, aspiration, angiotensin converting enzyme inhibitor, habit, psychogenic cough, interstitial lung disease, environmental and occupational factor, tuberculosis, obstructive sleep apnea, peritoneal dialysis, and idiopathic cough can be also considered as cause of chronic cough. Level of evidence for treatment is mostly low. Thus, in this guideline, many recommendations are based on expert opinion. Further study regarding treatment for cough is mandatory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.